Qtron Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Hold |
12,021
| – | – | 0.06% | 344 |
|
|
2025
Q1 | $466K | Sell |
12,021
-11,154
| -48% | -$432K | 0.07% | 305 |
|
|
2024
Q4 | $784K | Sell |
23,175
-16,488
| -42% | -$558K | 0.11% | 239 |
|
|
2024
Q3 | $1.62M | Sell |
39,663
-7
| -0% | -$286 | 0.22% | 96 |
|
|
2024
Q2 | $1.53M | Buy |
39,670
+7,859
| +25% | +$303K | 0.22% | 95 |
|
|
2024
Q1 | $1.36M | Hold |
31,811
| – | – | 0.19% | 122 |
|
|
2023
Q4 | $1.18M | Hold |
31,811
| – | – | 0.19% | 120 |
|
|
2023
Q3 | $1.15M | Buy |
31,811
+6,638
| +26% | +$241K | 0.22% | 103 |
|
|
2023
Q2 | $897K | Sell |
25,173
-7,772
| -24% | -$277K | 0.17% | 158 |
|
|
2023
Q1 | $1.17M | Sell |
32,945
-1,608
| -5% | -$57.2K | 0.24% | 100 |
|
|
2022
Q4 | $1.21M | Buy |
34,553
+24,632
| +248% | +$866K | 0.26% | 97 |
|
|
2022
Q3 | $292K | Sell |
9,921
-24,504
| -71% | -$721K | 0.07% | 339 |
|
|
2022
Q2 | $1.87M | Sell |
34,425
-1,249
| -4% | -$68K | 0.41% | 52 |
|
|
2022
Q1 | $1.94M | Hold |
35,674
| – | – | 0.43% | 51 |
|
|
2021
Q4 | $1.97M | Buy |
35,674
+9,201
| +35% | +$507K | 0.44% | 49 |
|
|
2021
Q3 | $1.26M | Buy |
26,473
+17,444
| +193% | +$833K | 0.34% | 68 |
|
|
2021
Q2 | $449K | Hold |
9,029
| – | – | 0.11% | 223 |
|
|
2021
Q1 | $403K | Buy |
9,029
+477
| +6% | +$21.3K | 0.11% | 222 |
|
|
2020
Q4 | $393K | Sell |
8,552
-2,013
| -19% | -$92.5K | 0.11% | 231 |
|
|
2020
Q3 | $497K | Sell |
10,565
-5,239
| -33% | -$246K | 0.17% | 141 |
|
|
2020
Q2 | $806K | Sell |
15,804
-4,676
| -23% | -$238K | 0.32% | 70 |
|
|
2020
Q1 | $970K | Buy |
20,480
+2,000
| +11% | +$94.7K | 0.58% | 39 |
|
|
2019
Q4 | $1.09M | Buy |
18,480
+2,664
| +17% | +$156K | 0.63% | 34 |
|
|
2019
Q3 | $844K | Buy |
+15,816
| New | +$844K | 0.51% | 52 |
|